{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:03:14Z","timestamp":1778900594254,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T00:00:00Z","timestamp":1402099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10096-014-2144-5","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T15:24:00Z","timestamp":1406388240000},"page":"1959-1966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China"],"prefix":"10.1007","volume":"33","author":[{"given":"Z.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Kam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,7]]},"reference":[{"issue":"1","key":"2144_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrmicro2048","volume":"7","author":"C Dye","year":"2009","unstructured":"Dye C (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 7(1):81\u201387","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"2144_CR2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","volume":"66","author":"PE Almeida Da Silva","year":"2011","unstructured":"Almeida Da Silva PE, Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 66(7):1417\u20131430","journal-title":"J Antimicrob Chemother"},{"key":"2144_CR3","unstructured":"World Health Organization (WHO) (2008) Anti-tuberculosis drug resistance in the world. Report no. 4. WHO, WHO\/HTM\/TB\/2008.394"},{"issue":"1","key":"2144_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","volume":"42","author":"D Falzon","year":"2013","unstructured":"Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH et al (2013) Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 42(1):156\u2013168","journal-title":"Eur Respir J"},{"issue":"7","key":"2144_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMp068273","volume":"356","author":"MC Raviglione","year":"2007","unstructured":"Raviglione MC, Smith IM (2007) XDR tuberculosis\u2014implications for global public health. N Engl J Med 356(7):656\u2013659","journal-title":"N Engl J Med"},{"issue":"3","key":"2144_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03256322","volume":"13","author":"SV Balasingham","year":"2009","unstructured":"Balasingham SV, Davidsen T, Szpinda I, Frye SA, T\u00f8njum T (2009) Molecular diagnostics in tuberculosis: basis and implications for therapy. Mol Diagn Ther 13(3):137\u2013151","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"2144_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/ers.09.45","volume":"3","author":"E Richter","year":"2009","unstructured":"Richter E, R\u00fcsch-Gerdes S, Hillemann D (2009) Drug-susceptibility testing in TB: current status and future prospects. Expert Rev Respir Med 3(5):497\u2013510","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"2144_CR8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JCM.43.8.3699-3703.2005","volume":"43","author":"D Hillemann","year":"2005","unstructured":"Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S (2005) Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 43(8):3699\u20133703","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2144_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S Ramaswamy","year":"1998","unstructured":"Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79(1):3\u201329","journal-title":"Tuber Lung Dis"},{"issue":"3","key":"2144_CR10","doi-asserted-by":"crossref","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","volume":"7","author":"SB Georghiou","year":"2012","unstructured":"Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC (2012) Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 7(3):e33275","journal-title":"PLoS One"},{"issue":"12","key":"2144_CR11","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","volume":"53","author":"L Jugheli","year":"2009","unstructured":"Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L (2009) High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 53(12):5064\u20135068","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2144_CR12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diagmicrobio.2013.06.031","volume":"77","author":"Q Du","year":"2013","unstructured":"Du Q, Dai G, Long Q, Yu X, Dong L, Huang H et al (2013) Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagn Microbiol Infect Dis 77(2):138\u2013142","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"2144_CR13","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(8):3192\u20133197","journal-title":"Antimicrob Agents Chemother"},{"issue":"47","key":"2144_CR14","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.1073\/pnas.0907925106","volume":"106","author":"MA Zaunbrecher","year":"2009","unstructured":"Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE (2009) Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 106(47):20004\u201320009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2144_CR15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jac\/dkr109","volume":"66","author":"A Engstr\u00f6m","year":"2011","unstructured":"Engstr\u00f6m A, Perskvist N, Werngren J, Hoffner SE, Jur\u00e9en P (2011) Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 66(6):1247\u20131254","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2144_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM (2005) Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(2):571\u2013577","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2144_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/00221287-88-2-269","volume":"88","author":"M Tsukamura","year":"1975","unstructured":"Tsukamura M, Mizuno S (1975) Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. J Gen Microbiol 88(2):269\u2013274","journal-title":"J Gen Microbiol"},{"issue":"3","key":"2144_CR18","doi-asserted-by":"crossref","first-page":"e32976","DOI":"10.1371\/journal.pone.0032976","volume":"7","author":"Y Pang","year":"2012","unstructured":"Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H et al (2012) Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7(3):e32976","journal-title":"PLoS One"},{"issue":"3","key":"2144_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2013.12.007","volume":"43","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Pang Y, Wang Y, Liu C, Zhao Y (2014) Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. Int J Antimicrob Agents 43(3):231\u2013235","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2144_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","volume":"10","author":"I Parwati","year":"2010","unstructured":"Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10(2):103\u2013111","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"2144_CR21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23):2161\u20132170","journal-title":"N Engl J Med"},{"issue":"2","key":"2144_CR22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/AAC.01024-12","volume":"57","author":"Y Pang","year":"2013","unstructured":"Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y (2013) Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob Agents Chemother 57(2):893\u2013900","journal-title":"Antimicrob Agents Chemother"},{"key":"2144_CR23","unstructured":"World Health Organization (WHO) (2009) Guidelines for surveillance of drug resistance in tuberculosis. Fourth edition (and supplementary materials). WHO, WHO\/HTM\/TB\/2009.422"},{"issue":"3","key":"2144_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.mimet.2011.05.016","volume":"86","author":"Y Pang","year":"2011","unstructured":"Pang Y, Zhou Y, Wang S, Lu J, Lu B, He G et al (2011) A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis. J Microbiol Methods 86(3):291\u2013297","journal-title":"J Microbiol Methods"},{"issue":"9851","key":"2144_CR25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","volume":"380","author":"T Dalton","year":"2012","unstructured":"Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN et al (2012) Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet 380(9851):1406\u20131417","journal-title":"Lancet"},{"issue":"11","key":"2144_CR26","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","volume":"53","author":"DA Duong","year":"2009","unstructured":"Duong DA, Nguyen TH, Nguyen TN, Dai VH, Dang TM, Vo SK et al (2009) Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob Agents Chemother 53(11):4835\u20134839","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2144_CR27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.meegid.2008.09.006","volume":"9","author":"L Rindi","year":"2009","unstructured":"Rindi L, Lari N, Cuccu B, Garzelli C (2009) Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms. Infect Genet Evol 9(1):48\u201353","journal-title":"Infect Genet Evol"},{"issue":"7","key":"2144_CR28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3201\/eid0907.020803","volume":"9","author":"M Ebrahimi-Rad","year":"2003","unstructured":"Ebrahimi-Rad M, Bifani P, Martin C, Kremer K, Samper S, Rauzier J et al (2003) Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 9(7):838\u2013845","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2144_CR29","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.01792-13","volume":"58","author":"LL Zhao","year":"2014","unstructured":"Zhao LL, Chen Y, Liu HC, Xia Q, Wu XC, Sun Q et al (2014) Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. Antimicrob Agents Chemother 58(4):1997\u20132005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2144_CR30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","volume":"42","author":"GJ Alangaden","year":"1998","unstructured":"Alangaden GJ, Kreiswirth BN, Aouad A, Khetarpal M, Igno FR, Moghazeh SL et al (1998) Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42(5):1295\u20131297","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2144_CR31","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/AAC.47.9.2971-2973.2003","volume":"47","author":"A Kr\u00fc\u00fcner","year":"2003","unstructured":"Kr\u00fc\u00fcner A, Jureen P, Levina K, Ghebremichael S, Hoffner S (2003) Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 47(9):2971\u20132973","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2144_CR32","first-page":"561","volume":"12","author":"L Jugheli","year":"2008","unstructured":"Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F (2008) High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Int J Tuber Lung Dis 12(5):561\u2013566","journal-title":"Int J Tuber Lung Dis"},{"issue":"7","key":"2144_CR33","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/JCM.06860-11","volume":"50","author":"X Yuan","year":"2012","unstructured":"Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J et al (2012) Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol 50(7):2404\u20132413","journal-title":"J Clin Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2144-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-014-2144-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-014-2144-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T06:30:39Z","timestamp":1565677839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-014-2144-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,7]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2144"],"URL":"https:\/\/doi.org\/10.1007\/s10096-014-2144-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,7]]}}}